Carregant...
The new era of immunotherapy in multiple myeloma: daratumumab and elotuzumab
OBJECTIVE: To review the clinical pharmacology, efficacy and safety of daratumumab and elotuzumab for the treatment of relapsed refractory multiple myeloma. DATA SOURCES: A literature search of Medline, PubMed, the U.S. National Institutes of Health Clinicaltrials.gov, the Food and Drug administrati...
Guardat en:
| Publicat a: | Ann Pharmacother |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5533303/ https://ncbi.nlm.nih.gov/pubmed/27083916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1060028016642786 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|